These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17 related articles for article (PubMed ID: 22826592)
1. Marketing trials, marketing tricks - how to spot them and how to stop them. Matheson A Trials; 2017 Mar; 18(1):105. PubMed ID: 28270221 [TBL] [Abstract][Full Text] [Related]
2. Income from reprints creates a conflict of interests. Lundh A; Hróbjartsson A; Gøtzsche PC BMJ; 2012 Jul; 345():e4970. PubMed ID: 22826593 [No Abstract] [Full Text] [Related]
3. Data availability for industry sponsored trials: what should medical journals require? Steinbrook R; Kassirer JP BMJ; 2010 Oct; 341():c5391. PubMed ID: 20940213 [No Abstract] [Full Text] [Related]
4. High reprint orders in medical journals and pharmaceutical industry funding: case-control study. Handel AE; Patel SV; Pakpoor J; Ebers GC; Goldacre B; Ramagopalan SV BMJ; 2012 Jun; 344():e4212. PubMed ID: 22745328 [TBL] [Abstract][Full Text] [Related]
5. Commentary: Journals must facilitate the dissemination and scrutiny of clinical research. Freemantle N BMJ; 2010 Oct; 341():c5397. PubMed ID: 20940214 [No Abstract] [Full Text] [Related]
6. Ghost story: at medical journals, writers paid by industry play big role. Mathews AW Wall St J (East Ed); 2005 Dec; ():A1, A8. PubMed ID: 16506304 [No Abstract] [Full Text] [Related]
7. Time to open up the finances of medical journals. Smith R BMJ; 2012 Jul; 345():e4968. PubMed ID: 22826592 [No Abstract] [Full Text] [Related]
8. Industry sponsorship and authorship of clinical trials over 20 years. Buchkowsky SS; Jewesson PJ Ann Pharmacother; 2004 Apr; 38(4):579-85. PubMed ID: 14982982 [TBL] [Abstract][Full Text] [Related]